US Stock MarketDetailed Quotes

RGBPP REGEN BIOPHARMA INC

Watchlist
  • 0.070
  • +0.010+16.47%
15min DelayClose Mar 14 16:00 ET
0Market Cap0.00P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Total revenue
0.00%236.56K
0.00%59.37K
0.00%59.07K
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
Operating revenue
0.00%236.56K
0.00%59.37K
0.00%59.07K
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
Cost of revenue
Gross profit
Operating expense
-29.10%654.75K
23.03%145.74K
15.82%167.03K
16.12%160.14K
-65.23%181.85K
60.58%923.51K
-24.62%118.45K
22.61%144.22K
2.26%137.91K
216.00%522.93K
Selling and administrative expenses
-29.55%501.06K
35.01%112.21K
35.59%134.53K
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
-General and administrative expense
-29.55%501.06K
35.01%112.21K
35.59%134.53K
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
Research and development costs
-27.61%153.69K
-5.13%33.52K
-27.78%32.5K
10.12%40.13K
-50.24%47.53K
-22.91%212.3K
-45.02%35.34K
44.88%45K
-43.38%36.45K
-17.44%95.51K
Operating profit
39.12%-418.19K
-46.18%-86.37K
-26.79%-107.97K
-28.19%-101.07K
73.53%-122.78K
-102.28%-686.95K
39.57%-59.09K
-44.55%-85.16K
-3.07%-78.84K
-335.87%-463.87K
Net non-operating interest income expense
20.20%-246.94K
31.75%-181.52K
-55.68%-21.89K
-77.10%-21.4K
-27.49%-22.13K
-21.43%-309.45K
-229.83%-265.94K
73.20%-14.06K
81.24%-12.09K
69.72%-17.36K
Non-operating interest income
----
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
70.64%101.44K
125.93%36.02K
55.68%21.89K
77.10%21.4K
27.49%22.13K
-71.66%59.45K
-54.70%15.94K
-73.27%14.06K
-81.27%12.09K
-69.79%17.36K
Total other finance cost
-41.80%145.5K
----
----
----
----
449.45%250K
----
----
----
----
Other net income (expense)
-109.39%-202.12K
2.99K
-261
-109.68%-204.85K
-29.13%2.15M
0
100.05%35.95K
-24.63%2.12M
Gain on sale of security
-109.39%-202.12K
--2.99K
---261
----
-109.68%-204.85K
-36.16%2.15M
--0
----
100.05%35.95K
-25.53%2.12M
Special income (charges)
----
----
----
----
--0
101.21%1.15K
--0
----
----
101.21%1.15K
-Less:Other special charges
----
----
----
----
----
-101.21%-1.15K
--0
----
----
-101.21%-1.15K
Income before tax
-174.99%-867.25K
18.50%-264.9K
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
Income tax
Net income
-174.99%-867.25K
18.50%-264.9K
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
Net income continuous Operations
-174.99%-867.25K
18.50%-264.9K
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
Minority interest income
Net income attributable to the parent company
-184.73%-867.25K
5.47%-264.9K
-18.03%-117.11K
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-184.73%-867.25K
5.47%-264.9K
-18.03%-117.11K
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Total revenue 0.00%236.56K0.00%59.37K0.00%59.07K0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K
Operating revenue 0.00%236.56K0.00%59.37K0.00%59.07K0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K
Cost of revenue
Gross profit
Operating expense -29.10%654.75K23.03%145.74K15.82%167.03K16.12%160.14K-65.23%181.85K60.58%923.51K-24.62%118.45K22.61%144.22K2.26%137.91K216.00%522.93K
Selling and administrative expenses -29.55%501.06K35.01%112.21K35.59%134.53K18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K
-General and administrative expense -29.55%501.06K35.01%112.21K35.59%134.53K18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K
Research and development costs -27.61%153.69K-5.13%33.52K-27.78%32.5K10.12%40.13K-50.24%47.53K-22.91%212.3K-45.02%35.34K44.88%45K-43.38%36.45K-17.44%95.51K
Operating profit 39.12%-418.19K-46.18%-86.37K-26.79%-107.97K-28.19%-101.07K73.53%-122.78K-102.28%-686.95K39.57%-59.09K-44.55%-85.16K-3.07%-78.84K-335.87%-463.87K
Net non-operating interest income expense 20.20%-246.94K31.75%-181.52K-55.68%-21.89K-77.10%-21.4K-27.49%-22.13K-21.43%-309.45K-229.83%-265.94K73.20%-14.06K81.24%-12.09K69.72%-17.36K
Non-operating interest income ----------------------0----------------
Non-operating interest expense 70.64%101.44K125.93%36.02K55.68%21.89K77.10%21.4K27.49%22.13K-71.66%59.45K-54.70%15.94K-73.27%14.06K-81.27%12.09K-69.79%17.36K
Total other finance cost -41.80%145.5K----------------449.45%250K----------------
Other net income (expense) -109.39%-202.12K2.99K-261-109.68%-204.85K-29.13%2.15M0100.05%35.95K-24.63%2.12M
Gain on sale of security -109.39%-202.12K--2.99K---261-----109.68%-204.85K-36.16%2.15M--0----100.05%35.95K-25.53%2.12M
Special income (charges) ------------------0101.21%1.15K--0--------101.21%1.15K
-Less:Other special charges ---------------------101.21%-1.15K--0---------101.21%-1.15K
Income before tax -174.99%-867.25K18.50%-264.9K-31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M
Income tax
Net income -174.99%-867.25K18.50%-264.9K-31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M
Net income continuous Operations -174.99%-867.25K18.50%-264.9K-31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M
Minority interest income
Net income attributable to the parent company -184.73%-867.25K5.47%-264.9K-18.03%-117.11K-122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -184.73%-867.25K5.47%-264.9K-18.03%-117.11K-122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.